Severance Hospital
Seoul, 120-752, South Korea
NCT Number: NCT01274130
This is the investigatory study to find out metformin's pharmacokinetics, pharmacodynamics and drug-drug interactions classifying the group by MATE1 genotype in healthy volunteers. The investigators will apply ranitidine and verapamil to the drug interaction study of metformin.
Looking for future studies?
Notify Me20 year–50 year
All sexes
Interventional
Not applicable
Seoul, 120-752, South Korea
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Diavex 1000mg on Day1 and 750mg on Day2
Other names: Diavex®
Yonsei University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07515417
Dyssomnias, Health Adult Subjects
Mecca, Saudi Arabia
View Trial DetailsNCT07707466
Chinese, Healthy Adult
Chicago, Illinois, United States
View Trial DetailsNCT07755267
Healthy Adult
Mississauga, Ontario, Canada
View Trial DetailsNCT07428889
Healthy Adult
Addison, Illinois, United States
View Trial Details